Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and -5 secretion by human T-helper type 2 cells

Immunopharmacology

Volumn 31, Issue 2-3, 1996, Pages 223-235

  Crocker, I Caroline ^a   Townley, Robert G ^a   Khan, Manzoor M ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

Cytokines; Interleukin 4; Interleukin 5; Phosphodiesterase inhibitors; Proliferation; TH2 human cell lines

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; INTERLEUKIN 4; INTERLEUKIN 5; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; HELPER CELL; HUMAN; LUNG LAVAGE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0029881921     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(95)00053-4     Document Type: Article

References (38)

1. Campbell HD, Tucker WQJ, Hort Y, Martinson ME, Mayo G, Clutterbuck EJ, Sanderson CJ, Young IG. Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5). Proc. Natl. Acad. Sci. USA 1987, 84: 6629-33.
2. Chan SC, Li S-H, Hanifin JM. Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition. J. Invest. Dermatol. 1993, 100: 681-4.
3. Chan SC, Hanifin JM. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes. J. Lab. Clin. Med. 1993, 121: 44-51.
4. Cooper KD, Kang K, Chan SC, Hanifin JM. Phosphodiesterase inhibition by Ro20-1724 reduces hyper-IgE synthesis by atopic dermatitis cells in vitro. J. Invest. Dermatol. 1985, 84: 477-82.
5. Corrigan CJ, Kay AB, CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am. Rev. Respir. Dis. 1990, 141: 970-7.
6. Del Prete G-F, Maggi E, Paronchi P, Chértien I, Tirl A, Macchia D, Ricci M, Banchereau J, de Vries J, Romagnani S. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J. Immunol. 1988, 140: 4193-8.
7. Del Prete G-F, De Carli M, Mastromauro C, Macchia D, Biagiotti R, Ricci M, Romagnani S. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 1991, 88: 346-50.
8. Dent G, Giembycz MA, Rabe KF, Wolf B, Barnes PJ, Magnussen H. Am. J. Respir. Cell Mol. Biol. 1994, 10: 565-72.
9. Essayan DM, Kagey-Sabotka A, Lichtenstein LM, Huang SK. Modulation of allergen-induced cytokine gene expression and proliferation by phosphodiesterase (PDE) inhibitors in vitro. J. Allergy Clin. Immunol. 1993, 92: 254.
10. Essayan DM, Huang S-K, Udem BJ, Kagey-Sobotka A, Lichtenstein LM. Modulation of antigen-and mitogen-induced proliferative responses of peripheral blood mononuclear cells by nonselective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors. J. Immunol. 1994, 153: 3408-16.
11. Fijisawa T, Abu-Ghazaleh R, Kita H, Sanderson CJ, Gleich GJ. Regulatory effect of cytokines on eosinophil degranulation. J. Immunol. 1990, 144: 642-6.
12. Giembycz MA. Could isozyme-specific phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma? Biochem. Pharmacol. 1992, 43: 2041-51.
13. Grew S, Chan SC, Hanifin JM. Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness. J. Allergy Clin. Immunol. 1982, 70: 452-7.
14. Khan MM, Tran A, Melmon KL. Autacoids selectively suppress interleukin-4 secretion. Eur. J. Pharm. 1990, 183: 624.
15. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 1988, 167: 219-24.
16. 2 like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J. Immunol. 1991, 146: 1169-74.
17. Mary D, Aussel C, Ferrua B, Fehlmann M. Regulation of interleukin 2 synthesis by cAMP in human T cells. J Immunol 1987, 139: 1179-84.
18. McLaughlin MM, Cieslinski, LB, Berman M, Torphy TJ, Livi GP. A low-Km rolipram-sensitive, cAMP phosphodiesterase from human brain. J. Biol. Chem. 1993, 268: 6470-6476.
19. Molnar-Kimber K, Yonno L, Heaslip R, Weichman B. Modulation of TNFα and IL-1β from endotoxin-stimulated monocytes by selective PDE isoenzyme inhibitors. Agents Actions 1993, 39: C77-9.
20. Nicholson CD, Challis RAJ, Shahid M. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol. Sci. 1991, 12: 19-27.
21. Nielson CP, Vestal RE, Sturm RJ, Heaslip R. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear elukocyte respiratory burst. J. Allergy Clin. Immunol. 1990, 86: 801-8.
22. Okayama H, Fushimi T, Shimura S, Sasaki H, Shirato K. Glucocorticoids suppressed production and gene expression of interleukin-5 by peripheral blood mononuclear cells in atopic patients and normal subjects. J. Allergy Clin. Immunol. 1994, 93: 1006-12.
23. Parronchi P, Macchia D, Piccinni M-P, Biswas P, Simonelli C, Maggi E, Ricci M, Ansari AA, Romagnani S. Allergen-and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc. Natl. Acad. Sci. 1991, 88: 4538-42.
24. Persson CG, Andersson KE, Kjellin G. Effects of enprofylline and theophylline may show role of adenosine. Life Science 1986, 38: 1057-72.
25. Plaut M, Marone G, Gillespie E. The role of cyclic AMP in modulating cytotoxic T lymphocytes II. Sequential changes during culture in reponsiveness of cytotoxic lymphocytes to cyclic AMP-active agents. J. Immunol. 1983, 131: 2945-52.
26. Robicsek S, Blanchard DK, Djeu J, Krzanowski JJ, Szentivanyi A, Polson JB. High pressure liquid chromatography of cyclic AMP phosphodiesterase from pruified human T lymphocytes. Biochem. Biophys. Res. Commun. 1989, 163: 554-60.
27. Robinson DS, Durham SR, Kay AB. Cytokines in Asthma. Thorax (England) 1993, 48: 845-53.
28. Romagnani S. Type 1 helper and type 2 helper cells: functions, regulation and role in protection and disease. Int. J. Lab. Clin. Res. 1991, 21(2): 152-8.
29. Saito H, Hatake K, Dvorak AM, Leiferman KM, Donnenberg AD, Arai N, Ishizaka K, Ishizaka T. Selective differentiation and proliferation of haematopoietic cells induced by recombinant human interleukins. Proc. Natl, Acad. Sci. USA 1988, 85: 2288-92.
30. Schumacher JH, O'Garra A, Shrader B, van Kimmenade A, Bond MW, Mosman TR, Coffman RL. The characterization of four monoclonal antibodies specific for mouse IL-5 and the development of mouse and human enzyme-linked immunosorbant. J. Immunol. 1988, 141: 1576-81.
31. 2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 1993, 150: 5321-9.
32. Sonoda Y, Arai N, Ogawa M. humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF), and interleukin-5. Leukemia 1989, 3: 14-8.
33. Sugiyama H, Okada C, Bewtra AK, Hopp RJ, Townley RG. The effect of formeterol on the late phase allergic phenomena in guinea pigs. J. Allergy Clin. Immunol. 1992, 89: 858-66.
34. Townley RG. Elevated cAMP-phosphodiesterase in atopic disease: Cause or effect? J. Lab. Clin. Med. 1993, 121(1): 15-7.
35. Torphy TJ, Undem DJ. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 1991, 46: 512-23.
36. Turner CR, Andresen CJ, Smith WB, Watson JW. Effects of rolipram on responses to acute and chronic antigan exposure in monkeys. J. Respir. Crit. Care Med. 1994, 149: 1153-9.
37. Van Reijsen FC, Bruijnzeel-Koomen CAFM, Kalthoff FS, Magge E, Romagnani S, Westland JKT, Mudde GC. Skin-derived aeroallergen specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J. Allergy Clin. Immunol. 1992, 90: 184-92.
38. Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology 1990, 71: 258-65.